Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of P2RX7 functional SNPs on osteoblast cell phenotype, function and signalling- roles in bone homeostasis and osteogenesis.

Purinergic signalling·2026
Same author

Unveiling the molecular crosstalk between the purinergic P2X7 receptor and cannabinoid subtype 2 receptor in human microglial HMC3 cells: New insights for multitarget therapies in neuroinflammation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Benzamide derivatives as allosteric ligands of the human and rat P2X7 receptor.

Purinergic signalling·2026
Same author

Methodological guidelines for P2X receptor assays and data interpretation.

Cell death & disease·2026
Same author

P2X receptors in immune cells: key regulators of inflammation and immune function.

Neuropharmacology·2026
Same author

A Holistic Approach to Identifying a Positron Emission Tomography (PET) Tracer Candidate for In Vivo Imaging of Purinergic P2X7 Receptor in Neuroinflammation.

ACS pharmacology & translational science·2026

Related Experiment Video

Updated: Nov 11, 2025

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
11:47

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells

Published on: April 3, 2019

9.5K

P2X7 Receptor in Hematological Malignancies.

Elena De Marchi1, Anna Pegoraro1, Elena Adinolfi1

  • 1Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Frontiers in Cell and Developmental Biology
|March 25, 2021
PubMed
Summary

The P2X7 receptor (P2X7R) plays a key role in immune responses and cancer. Alterations in P2X7R are linked to hematological malignancies, suggesting its potential as a biomarker and therapeutic target.

Keywords:
ATPP2X7 receptorleukemialymphomamultiple myeloma

More Related Videos

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

804
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.3K

Related Experiment Videos

Last Updated: Nov 11, 2025

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
11:47

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells

Published on: April 3, 2019

9.5K
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

804
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.3K

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • The P2X7 receptor (P2X7R), an ATP-gated ion channel, is crucial in immune responses.
  • P2X7R is increasingly recognized for its role in promoting cancer development.
  • Its expression is established in immune cells, linking P2X7R alterations to hematological malignancies.

Purpose of the Study:

  • To review literature on the role of P2X7R in the development of leukemias, lymphomas, and multiple myeloma.
  • To highlight recent findings on P2X7R in the leukemic microenvironment and its association with acute myeloid leukemia.
  • To explore the potential of P2X7R as a biomarker and therapeutic target in hematological cancers.

Main Methods:

  • Literature review of established and recent studies.
  • Focus on research correlating P2X7R with ATP levels in leukemia.
  • Analysis of studies linking P2X7R overexpression to acute myeloid leukemia (AML) prognosis.

Main Results:

  • P2X7R alterations are implicated in the insurgence and progression of hematological malignancies.
  • Recent studies link P2X7R to ATP concentration in the leukemic microenvironment.
  • P2X7R overexpression correlates with AML aggressiveness and chemotherapy response.

Conclusions:

  • P2X7R and its genetic variants show promise as biomarkers for hematological malignancies.
  • P2X7R antagonists and agonists represent potential novel therapeutic strategies.
  • Targeting P2X7R could be beneficial alone or in combination with existing chemotherapy.